4,500 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by XTX Topco Ltd

XTX Topco Ltd acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,500 shares of the company's stock, valued at approximately $432,000.

A number of other institutional investors also recently made changes to their positions in the stock. Pier Capital LLC purchased a new stake in HealthEquity during the 4th quarter worth $8,024,000. HighTower Advisors LLC increased its position in HealthEquity by 4.8% in the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after buying an additional 4,370 shares during the period. Geneva Capital Management LLC boosted its stake in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock valued at $100,642,000 after purchasing an additional 206,894 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of HealthEquity by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock worth $104,280,000 after buying an additional 25,004 shares during the period. Finally, Wells Fargo & Company MN grew its stake in shares of HealthEquity by 4.7% in the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock worth $11,988,000 after purchasing an additional 5,594 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,381 shares of company stock valued at $1,781,432 over the last ninety days. 2.20% of the stock is currently owned by company insiders.

HealthEquity Stock Up 0.0 %

NASDAQ HQY traded up $0.04 during trading hours on Friday, hitting $85.87. 559,483 shares of the company traded hands, compared to its average volume of 770,768. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business's 50-day moving average is $92.41 and its 200-day moving average is $96.39. The stock has a market capitalization of $7.43 billion, a price-to-earnings ratio of 78.78, a P/E/G ratio of 1.60 and a beta of 0.49.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. KeyCorp reduced their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. The Goldman Sachs Group cut their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Finally, Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $111.75.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.